Domperidone is a medicine intended to treat digestion, nausea and vomiting in children and adults, and should be used for less than a week.
This drug can be found under trade names such as Motilium, Moperidone, Restol, Agilam, Idom, Tilium, Seronex, among others and available in tablet form or drinkable suspension in drops, so it is used under medical supervision.
- This medicine is intended to treat digestion problems frequently associated with delayed gastric vacancy.
- Gastroesophageal reflux disease and esophagitis.
- Early satiety.
- Fatigue.
- Bloating.
- High abdominal pain.
- Excess gas and intestinal.
- Nausea and vomiting.
- Nausea and vomiting.
- Acidity and burning.
- In the stomach with regurgitation of the gastric content.
In addition to this, it is also indicated in cases of nausea and vomiting of functional, organic, infectious or nutritional origin, induced by radiation therapy or pharmacological treatment.
Domperidone should be taken between 15 and 30 minutes before meals and, if necessary, if necessary.
For adults and adolescents weighing more than 35 kg, doses of 10 mg, 3 times daily, should not be exceeded orally, but the maximum dose of 40 mg should not be exceeded.
In infants and children under 12 years of age or under 35 kg, the recommended dose is 0. 25 ml/ kg body weight, up to 3 times daily, orally.
The most common side effects that can occur during treatment with domperidone in depression, anxiety, sexual appetite, headache, drowsiness, anxiety, diarrhea, rash, itching, increased breast tenderness and tenderness, milk production, lack of menstrual appetite, breast pain and muscle weakness.
Domperidone is contraindicated during the embargo where it exists, unless, at the doctor’s discretion, the relationship between risk and fetal maternal benefit is favorable. If the use of this medicine during lactation is essential, it should be temporarily discontinued during the lactation period. treatment, as there are no studies that show that the baby is not serious.
This medicine is also contraindicated in patients with known intolerance to domperidone or any of its components, in the presence of a prolactin-secreting pituitary tumor and in cases of gastrointestinal bleeding, mechanical obstruction and intestinal perforation.
Administration of a set of domperidone and heart rate-altering drugs such as itraconazole, ketoconazole, posaconazole, voriconazole, erythromycin, clarithromycin, telitromycin, amioda, ritonavir and saquinavir is contraindicated.